According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses the user experience of hospital IT systems. For the Bill Crounse, MD blog visit: HealthBlog For more…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
In a phase III, randomized, open-labeled, noninferiority study that compared clinical cure of ventilator-associated pneumonia with doripenem IV with two different does of imipenem IV, length of stay…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his thoughts on…
A tablet that combines sumatriptan and naproxen (Treximet) has been approved by the FDA for treatment of migraine with and without aura. References and Resources FDA Sponsored by…
An investigational compound for chronic plaque psoriasis has shown to be safe and effective. In an industry-sponsored phase III trial, the calcineurin inhibitor ISA247 significantly reduced the extent…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington, discusses the Center for Advanced Brain Tumor Treatment. For more information visit: Center…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer. References and Resources Schönekaes K, Mücke R,…
A feasibility study presented at the American Association for Cancer Research meeting showed that intraductal chemotherapy may have potential as a treatment for ductal carcinoma in situ and…
